The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of recombinant interleukin-15 in combination with checkpoint inhibitors nivolumab and ipilimumab in subjects with refractory cancers.
 
Geraldine Helen O'Sullivan Coyne
No Relationships to Disclose
 
Kevin Conlon
No Relationships to Disclose
 
Naoko Takebe
No Relationships to Disclose
 
Howard Streicher
No Relationships to Disclose
 
Mary Flanagan Quinn
No Relationships to Disclose
 
Ashley Bruns
No Relationships to Disclose
 
Tony Navas
No Relationships to Disclose
 
Ralph E. Parchment
Employment - Leidos Biomedical Research
Stock and Other Ownership Interests - SciTech Development LLC
Patents, Royalties, Other Intellectual Property - Cambridge University Press for The Biological Basis of Cancer; Named inventor on US Patent US8709379 B2
 
Larry Rubinstein
No Relationships to Disclose
 
Elad Sharon
No Relationships to Disclose
 
James H. Doroshow
No Relationships to Disclose
 
Thomas A. Waldmann
No Relationships to Disclose
 
Alice P. Chen
No Relationships to Disclose